NCT05688085已完成1 期
A Randomized, Open-label, Crossover, Phase 1 Study to Evaluate Pharmacokinetics and Safety of Irbesartan High/Amlodipine Fixed Dose Combination in Comparison With Co-administration of Mono Compounds in Healthy Volunteers
适应症
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- Handok Inc.
- 入组人数
- 44
- 试验地点
- 1
- 主要终点
- AUCt of Irbesartan High and Amlodipine
研究概览
简要总结
The purpose of this study is to compare pharmacokinetics and safety of Irbesartan High and Amlodipine Fixed Dose Combination and coadministration of mono compounds in healthy adult volunteers
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 19 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Patients who are 19 years or older on screening
- •Signed informed consent
- •Healthy Volunteer
- •Other inclusion applied
排除标准
- •Clinically relevant/significant findings as evaluated by the investigator
- •Other exclusion applied
研究组 & 干预措施
Irbesartan High/Amlodipine Fixed dose combination
Experimental
participants will receive one tablet of Irbesartan High/Amlodipine FDC in a crossover design
干预措施: Irbesartan High/Amlodipine FDC (Drug)
Co-administration of Irbesartan High and Amlodipine
Experimental
participants will receive one table each of Irbesartan High and Amlodipine in a crossover design
干预措施: Irbesartan High (Drug)
Co-administration of Irbesartan High and Amlodipine
Experimental
participants will receive one table each of Irbesartan High and Amlodipine in a crossover design
干预措施: Amlodipine (Drug)
结局指标
主要结局
AUCt of Irbesartan High and Amlodipine
时间窗: 72 hours
Cmax of Irbesartan High and Amlodipine
时间窗: 72 hours
次要结局
- AUCinf of Irbesartan High and Amlodipine(72 hours)
- tmax of Irbesartan High and Amlodipine(72 hours)
- Vz/F of Irbesartan High and Amlodipine(72 hours)
- AUCt/AUCinf of Irbesartan High and Amlodipine(72 hours)
- half-life of Irbesartan High and Amlodipine(72 hours)
- CL/F of Irbesartan High and Amlodipine(72 hours)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
Pharmacokinetics of Irbesartan/Amlodipine High FDC and Co-administration of Irbesartan and Amlodipine High in Healthy VolunteersHealthy VolunteersNCT05688098Handok Inc.44
已完成
1 期
Pharmacokinetics of Irbesartan/Amlodipine FDC and Co-administration of Irbesartan and Amlodipine in Healthy VolunteersHealthy VolunteersNCT05663073Handok Inc.46
已完成
3 期
Clinical Efficacy and Safety Evaluation of Irbesartan and Amlodipine Combined Therapy in Essential Hypertension PatientsEssential HypertensionNCT05476354Handok Inc.271
已完成
3 期
Clinical Efficacy and Safety Evaluation of Irbesartan High and Amlodipine Combined Therapy in Essential Hypertension PatientsEssential HypertensionNCT05475665Handok Inc.157
已完成
3 期
Efficacy and Safety of Valsartan in Combination With Amlodipine Compared to Losartan Plus Hydrochlorothiazide in Patients With Hypertension and Left Ventricular HypertrophyHypertrophy, Left Ventricular HypertensionNCT00446563Novartis90